Veramaris is a 50:50 joint venture of DSM and Evonik for the production of the omega-3 fatty acids EPA and DHA from natural marine algae.
Located in Delft, the Netherlands, Veramaris was launched in 2018, because its parent companies shared a vision: to conserve marine life by using a resource the ocean provides – natural marine microalgae.
Producing an algal oil rich in the two essential omega-3 fatty acids EPA and DHA through large-scale fermentation at its facility in Blair, Nebraska, USA, Veramaris enables partners along the value chain to become independent from wild-caught fish and meet the growing demand for animal protein responsibly.
Thai Union records 1Q24 net profit of USD 32.49 M Thailand
Net profit increased 53.9 percent from 1Q23 adjusted net profit to THB 1.2 billion (USD 32.49 M) due to a healthier operating profit
Gross profit margin improved to 17.3 percent, with stron...